Sort
16,300 grants matching “fatty liver disease”
Development of ferroptosis inhibitors for Huntington Disease
$389,574Brent R Stockwell · Columbia Univ New York Morningside · R33 · FY2021 · NS
Metabolism of the VLDL receptor and ApoE receptor 2
$389,550Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2014 · HL
Role of heat shock protein 90 in alcoholic liver disease
$389,500Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · AA
Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates
$389,479Ye Ding · Georgia State University · R01 · FY2021 · HL
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
$389,426Andrew Patterson · Pennsylvania State University, The · R01 · FY2015 · ES
Lipid Binding Proteins in Obesity and Diabetes Syndromes
$389,372David A Bernlohr · University Of Minnesota · R01 · FY2020 · DK
Lipid Binding Proteins in Obesity and Diabetes Syndromes
$389,372David A Bernlohr · University Of Minnesota · R01 · FY2019 · DK
Modified Intestinal apoAI-particles and Lymphatics Accelerate CKD-driven CVD
$389,250Valentina Kon · Vanderbilt University Medical Center · P01 · FY2024 · HL
The Role of Bacterial Choline Metabolism in Host Stress Responses
$389,246Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · DK
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients
$389,221Michael B Rothberg · Cleveland Clinic Foundation · R01 · FY2022 · HS
Heat shock protein 90 in alcoholic liver disease: targeting macrophage function
$389,200Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AA
Role of SH2-B in Glucose Metabolism
$389,129Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2009 · DK
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients
$389,092Michael B Rothberg · Cleveland Clinic Foundation · R01 · FY2021 · HS
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
$389,052Aaron Grossberg · Oregon Health & Science University · R37 · FY2023 · CA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2019 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2022 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2021 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2020 · AA
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
$389,037David Oupicky · University Of Nebraska Medical Center · R01 · FY2023 · AA
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
$389,028Jessica L Maiers · Indiana University Indianapolis · R01 · FY2025 · DK
Lipotoxicity in Alcoholic Liver Disease
$388,951Zhanxiang Zhou · University Of North Carolina Greensboro · R01 · FY2015 · AA
Molecular Pharmacology of Insulin Resistance in Burns
$388,933Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2010 · GM
Molecular basis of fatty acid transport by peroxisomal ABC transporters
$388,933Amer Alam · University Of Minnesota · R01 · FY2022 · GM
Hepatitis B Clinical Research Network
$388,900Arun J Sanyal · Virginia Commonwealth University · U01 · FY2009 · DK
Physiology, pathology and animal core
$388,881Richard C Davis · University Of California Los Angeles · P01 · FY2015 · HL